Home Tags Pharmaceuticals

Tag: Pharmaceuticals

Patent Settlements and Reverse Payments Under EU Law

Marc van der Waude, Marc van der Waude, Nov 01, 2009 The purpose of this contribution is to explore the status types that settlements and...

The Second Circuit Cautiously Expands Walker Process Standing in In re...

This article is part of a Chronicle. See more from this Chronicle Charlene Jones, Aidan Synnott, Nov 25, 2009 In October 2009, the United States Court...

Reversing the Trend? The Possibility that Rule Changes May Lead to...

Anne Layne-Farrar, Nov 01, 2009 This article begins by laying out a simple framework that makes obvious the incentives at play in generic drug entry,...

Whistling Past the Graveyard: The Problem with the Per Se Legality...

Michael Kades, Nov 01, 2009 Arguably, the most important debate in antitrust jurisprudence involves pay-for-delay patent settlements in which the brand company pays the generic...

Review of Reverse-Payment Agreements: The Agencies, the Courts, Congress, and the...

Elai Katz, William Rooney, Nov 01, 2009 Two bills seeking to ban reverse-payment agreements are currently pending in Congress, and the European Commission has declared...

Dominant Firms’ Duties to Deal with Pharmaceutical Parallel Traders Following Glaxo...

Louise Macnab, Robert O'Donoghue, Apr 15, 2009 EU competition policy on dominant firms and pharmaceutical parallel trade wholesalers taking advantage of arbitrage possibilities to export...

The Intersection of Antitrust, Patents, and FDA Law: The TriCor Litigation

This article is part of a Chronicle. See more from this Chronicle Richard Epstein, Mar 26, 2009 The purpose of this brief essay is to address...

From Walker Process to In re DDAVP: Should Direct Purchasers Have...

This article is part of a Chronicle. See more from this Chronicle Aidan Synnott, Nov 29, 2008 In In re: DDAVP Direct Purchaser Antitrust Litigation, decided...

Innovation Markets after Genzyme/Novazyme

This article is part of a Chronicle. See more from this Chronicle Richard Gilbert, Jul 12, 2008 The U.S. Federal Trade Commission alleged adverse effects on...

News

Antitrust Mix by CPI